Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer

BACKGROUND: Combination chemotherapy is associated with improved outcomes in trials of selected fit patients with advanced colorectal cancer (acrc). For older or less-fit patients, combination chemotherapy is associated with greater toxicity and less benefit. Capecitabine monotherapy is a reasonable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Vincent, M.D., Breadner, D., Cripps, M.C., Jonker, D.J., Klimo, P., Biagi, J.J., Lam, W., O’Connell, A., Whiston, F., Stitt, L., Welch, S.A.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576465/
https://ncbi.nlm.nih.gov/pubmed/28874896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3516
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados